<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221011056145N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-30</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>Comparative study of pre-medication with paracetamol, Ibuprofen and placebo on post operative  pain following pulpotomy in 6-12 years old children</public_title>
      <acronym></acronym>
      <scientific_title>A split‐mouth randomized controlled trial: Comparative study of pre-medication with paracetamol, Ibuprofen and placebo on post operative  pain following pulpotomy in 6-12 years old children</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>27</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66345</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A random block of 3 was used for randomization.For this reason, based on the following randomization list, patients will receive the following treatments in the order of entering the study.Group A paracetamol, group B ibuprofen and group C placebo.In the same way, in the second measurement based on random selection using a coin, the group receiving paracetamol will receive placebo;The group receiving ibuprofen received paracetamol and the group receiving placebo received ibuprofen.In the last round, any treatment group that did not receive it will receive it. Randomization was done with SAS software version 9, Blinding description: Participants of this study have no information of their consuming syrup.
The therapist has no knowledge of the syrup consumed by the patients.
The statistics analyst does not know about the syrup consumed by the patients.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pulpotomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Ibuprofen. Ibuprofen suspension 100 mg/5 ml (Iran, Tehran, Hakim) is given 45 minutes before treatment based on the weight of each child. Intervention 2: Intervention group: Paracetamol. Paracetamol syrup 120 mg/5 ml (Tehran, Iran, Korizan) is given 45 minutes before treatment based on the weight of each child. Intervention 3: placebo suspension is given to children 45 minutes before treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data is shared, such as information on pain reduction after pulpotomy

When:
After printing the results

To whom:
Dentists, pediatricians, researchers working in academic and scientific institutions

Conditions:
Using pre-treatments such as ibuprofen, paracetamol and placebo to reduce pain after pulpotomy.

Where to obtain:
Gilan University of Medical Sciences Library

How to obtain:
Refer to the website of the library of Gilan Faculty of Dentistry and search in defended theses and approved research projects from 2021 onwards.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedeh Hedyeh Daneshvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Complex of Gilan University of Medical Sciences.,Saravan beltway to Foman</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>73774 41941</zip>
        <telephone>+98 13 3348 6406</telephone>
        <email>dr.daneshvar@gums.ac.ir</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>seyedeh Hedyeh Daneshvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Complex of Gilan University of Medical Sciences.,Saravan beltway to Foman</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4194173774</zip>
        <telephone>+98 13 3348 6406</telephone>
        <email>dr.daneshvar@gums.ac.ir</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The children be 6-12 years old
Each patient must have at least 3 teeth for Pulpotomy and SSC in lower jaw
Parents' consent to perform the treatment</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Not reaching hemostasis
Not reaching adequate anesthesia
Any kind of systemic disease that is in contrast to conservative pulp treatment
Any radiographic findings including:internal and external resorption, PDL Widening,furcation and periapical radiolucency,root canal calcification
Patients with any history of allergy to analgesics or any drugs used in the study
Patients are not reachable through phone call
Patients with Gastrointestinal problems, Favism, GERD,Active asthma
Patients with prolonged bleeding history
Presence of abscess or sinus tract</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K04.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Inflammation of the dental pulp, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may als</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Ibuprofen. Ibuprofen suspension 100 mg/5 ml (Iran, Tehran, Hakim) is given 45 minutes before treatment based on the weight of each child.</i_keyword>
      <i_keyword>Intervention group: Paracetamol. Paracetamol syrup 120 mg/5 ml (Tehran, Iran, Korizan) is given 45 minutes before treatment based on the weight of each child.</i_keyword>
      <i_keyword>placebo suspension is given to children 45 minutes before treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Examining the type of drug on pain after pulpotomy treatment. Timepoint: The treatments are done with an interval of one week, and the child is asked to paint the face that is most similar to his feeling about the treated tooth in the intervals of 24, 48, 72 hours after the treatment. Method of measurement: comparative investigation of pre-treatment with paracetamol, ibuprofen and placebo on pain after pulpotomy treatment in children 6-12 years old" the way of measuring the outcome variable is "Wong-Baker scale".</prim_outcome>
      <prim_outcome>Examining the age variable on pain after treatment. Timepoint: In the initial treatment session, the age is asked and recorded for each child. Method of measurement: In the initial treatment session, the age is asked and recorded for each child.</prim_outcome>
      <prim_outcome>Examining the gender variable on pain after treatment. Timepoint: In the initial treatment session, the gender of the child is asked and noted. Method of measurement: In the initial treatment session, the gender of the child is asked and noted.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-20</approval_date>
        <contact_name>Ethics committee of gilan university of medical Sciences</contact_name>
        <contact_address>Gilan Province, Fouman - Saravan Rd, Guilan Academic Complex of Medical Sciences Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
